Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	129.97	297.26	381.39	155.39	183.26
Cash & Short-Term Investments	129.97	297.26	381.39	155.39	183.26
Cash Growth	-56.28%	-22.06%	145.45%	-15.21%	-36.26%
Accounts Receivable	78.13	38.8	1.64	-	-
Inventory	5.52	3.21	1.21	-	-
Other Current Assets	15.35	20.87	13.19	5.13	3.27
Total Current Assets	228.97	360.13	397.43	160.51	186.53
Net Property, Plant & Equipment	3.67	2.09	3.62	3.49	2.56
Other Long-Term Assets	26.51	16.1	12.79	0.8	0.34
Total Assets	259.15	378.32	413.84	164.81	189.43
Accounts Payable	4.98	10.51	12.6	10	5.15
Accrued Expenses	91.66	54.94	18.34	15.53	13.28
Current Portion of Leases	0.65	0.5	0.73	0.71	0.49
Other Current Liabilities	34.75	19.78	7.11	-	-
Total Current Liabilities	132.04	85.73	38.78	26.24	18.92
Long-Term Debt	209.09	201.41	137.84	95.26	89.67
Long-Term Leases	2.07	-	0.46	1.1	1.18
Other Long-Term Liabilities	354.12	344.76	309.52	117.03	7.5
Total Long-Term Liabilities	565.27	546.17	447.82	213.39	98.35
Total Liabilities	697.32	631.9	486.6	239.62	117.28
Common Stock	0.01	0.01	0	0	0
Additional Paid-in Capital	1,046	1,009	855.92	652.28	601.52
Retained Earnings	-1,484	-1,263	-928.69	-727.09	-529.37
Shareholders' Equity	-438.17	-253.58	-72.76	-74.81	72.16
Total Liabilities & Equity	259.15	378.32	413.84	164.81	189.43
Total Debt	211.8	201.91	139.03	97.07	91.34
Net Cash (Debt)	-81.83	95.35	242.36	58.32	91.92
Net Cash Growth	-	-60.66%	315.61%	-36.56%	-61.46%
Net Cash Per Share	-1.12	1.51	4.72	1.49	2.48
Book Value	-438.17	-253.58	-72.76	-74.81	72.16
Book Value Per Share	-6.01	-4.01	-1.42	-1.91	1.95
Tangible Book Value	-438.17	-253.58	-72.76	-74.81	72.16
Tangible Book Value Per Share	-6.01	-4.01	-1.42	-1.91	1.95

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q